Check out our COVID-19 dedicated page for tenders related to medical equipment needs.
Netherlands-Amsterdam: Drug Pipeline Database
Section I: Contracting authority
Section II: Object
Drug Pipeline Database
The Agency requires access to current, comprehensive and complete drug databases to provide scientific, economic and industry-related information of the medicines and medical devices for human use in clinical practice and in research and development worldwide and of their developers and marketing authorisation holders, to inform the assessment and monitoring of these products by the Agency and to support its work forecast. The Agency is also looking for abstracted adverse reaction reports to find and/or evaluate adverse reactions of medicines for human use licensed in the EEA.
European Medicines Agency
Domenico Scarlattilaan 6
1083 HS Amsterdam
Subscription to one or several databases containing lifecycle and adverse reaction report data about medicinal products and medical devices for human use worldwide from pre-clinical to clinical studies phase IV up to and including marketing and discontinued projects; including scientific (therapeutic areas, mechanisms of action, indications in development, (bio-)chemical class, INN and product names, product safety and efficacy, routes of administration, formulations, orphan status, generics and biosimilars, abstracted public adverse reaction reports, etc.), economic (patent expiration, M&A, reimbursement status, etc.) and industry related information (company revenue, company deals, company pipeline, etc.) divided by major regional markets (EU, USA, Japan, BRIC).
See Internet address provided in Section I.3.
Section III: Legal, economic, financial and technical information
Section IV: Procedure
See Internet address provided in Section I.3
Section VI: Complementary information